BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 2988377)

  • 1. Retroviral-associated eosinophilic leukemia in the cat.
    Lewis MG; Kociba GJ; Rojko JL; Stiff MI; Haberman AB; Velicer LF; Olsen RG
    Am J Vet Res; 1985 May; 46(5):1066-70. PubMed ID: 2988377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of feline leukemia virus subgroup A infection by coinoculation with subgroup B.
    Phipps AJ; Hayes KA; Al-dubaib M; Roy-Burman P; Mathes LE
    Virology; 2000 Nov; 277(1):40-7. PubMed ID: 11062034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
    Hoover EA; Olsen RG; Mathes LE; Schaller JP
    Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antibody infusion on pathogenesis of experimental feline leukemia virus infection.
    Haley PJ; Hoover EA; Quackenbush SL; Gasper PW; Macy DW
    J Natl Cancer Inst; 1985 Apr; 74(4):821-7. PubMed ID: 2985857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
    Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B
    J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of feline leukemia virus immunity.
    Charreyre C; Pedersen NC
    J Am Vet Med Assoc; 1991 Nov; 199(10):1316-24. PubMed ID: 1666074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant feline leukemia virus (FeLV) variants establish a limited infection with altered cell tropism in specific-pathogen-free cats in the absence of FeLV subgroup A helper virus.
    Bechtel MK; Hayes KA; Mathes LE; Pandey R; Stromberg PC; Roy-Burman P
    Vet Pathol; 1999 Mar; 36(2):91-9. PubMed ID: 10098636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays.
    Tandon R; Cattori V; Willi B; Lutz H; Hofmann-Lehmann R
    Vet Immunol Immunopathol; 2008 May; 123(1-2):129-33. PubMed ID: 18295344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity of a subgroup C feline leukemia virus (FeLV) is augmented when administered in association with certain FeLV recombinants.
    Mathes LE; Pandey R; Chakrabarti R; Hofman FM; Hayes KA; Stromberg P; Roy-Burman P
    Virology; 1994 Jan; 198(1):185-95. PubMed ID: 8259654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70.
    Snyder HW; Singhal MC; Hardy WD; Jones FR
    J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable suppression of feline bone marrow fibroblast colony-forming units by two isolates of feline leukemia virus.
    Wellman ML; Kociba GJ; Mathes LE
    Am J Vet Res; 1991 Nov; 52(11):1924-7. PubMed ID: 1664674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural immunity in cats to feline leukemia viral antigens.
    Ruscetti SK; Parks WP
    J Immunol; 1976 Nov; 117(5 Pt.2):2029-35. PubMed ID: 186536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure.
    Legendre AM; Hawks DM; Sebring R; Rohrbach B; Chavez L; Chu HJ; Acree WM
    J Am Vet Med Assoc; 1991 Nov; 199(10):1456-62. PubMed ID: 1666103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of humoral immunity tests in FeLV infected cats.
    Charreyre CE; Pedersen N
    Dev Biol Stand; 1990; 72():197-200. PubMed ID: 2178116
    [No Abstract]   [Full Text] [Related]  

  • 17. Feline leukemia virus variants in experimentally induced thymic lymphosarcomas.
    Pandey R; Bechtel MK; Su Y; Ghosh AK; Hayes KA; Mathes LE; Roy-Burman P
    Virology; 1995 Dec; 214(2):584-92. PubMed ID: 8553560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline Leukemia Virus (FeLV) Endogenous and Exogenous Recombination Events Result in Multiple FeLV-B Subtypes during Natural Infection.
    Erbeck K; Gagne RB; Kraberger S; Chiu ES; Roelke-Parker M; VandeWoude S
    J Virol; 2021 Aug; 95(18):e0035321. PubMed ID: 34232703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A.
    Boomer S; Gasper P; Whalen LR; Overbaugh J
    Virology; 1994 Nov; 204(2):805-10. PubMed ID: 7941350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
    Lutz H; Pedersen NC; Theilen GH
    Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.